Request free access to get started
ISPOR 2026
HEOR at the Forefront of Policy, Access, and Value
18 presentations. One mission.
May 17 – 20 2026
Philadelphia, PA
Musat M, Rege J, Liu R, et al. Advancing personalized management in multiple myeloma: the untapped value of minimal residual disease-guided treatment [abstract]. HemaSphere. 2026;10(S1):PB3356.
How many studies with ADC are in breast cancer